ILMN
IlluminaCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
Current thesis
The post-earnings read-through improved: Q1 revenue grew 4.8% year over year, ROW organic growth was 3.5%, free cash flow improved, and management raised FY2026 revenue and EPS guidance while citing increasing NovaSeq X demand and clinical expansion. Early secondary coverage also pointed to at least one positive post-print revision, with Evercore ISI reportedly raising its target to $155 from $150 on May 1, 2026.
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.1.
What can break
China remains a live headwind, with the company still flagging uncertainty tied to its inclusion on the 'unreliable entities list' and ongoing regional demand effects.
Momentum
85
Value
62
Sentiment
20
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $136.00 · Bull $155.00 · Bear $115.00
Data freshness
Prices
As of 2026-07-20
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-20 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-03 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-07-20
Investment thesis
As of 2026-07-20
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $172.50
Why
Momentum85 · Δ7d +3.3
Value62 · Δ7d +0.1
Sentiment20 · Δ7d -0.7
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Value · See fundamentals
Momentum
85
26% active weight
Current posture
7d trendImproving
Δ7d
+3.3
Δ21d
-6.2
Value
62
39% active weight
Current posture
7d trendFlat
Δ7d
+0.1
Δ21d
-0.2
Sentiment
20
34% active weight
Current posture
7d trendFlat
Δ7d
-0.7
Δ21d
-5.6
Why this grade
Composite grade C. Momentum 85.0 / Value 61.8 / Sentiment 19.6
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$27.94B
Beta
1.45
Shares Out
151.3M
P/E (TTM)
31.6
P/S (TTM)
5.04
P/FCF (TTM)
21.60
Rev YoY
+4.8%
EPS YoY
+5.6%
Gross Margin
+67.1%
Op Margin
+18.1%
Net Debt
$920M
Current Ratio
1.75
As of 2026-07-20 • Updated nightlySource: Internal modelMethodology